10-Q: Horizon Tech Finance Q2 2025: NAV Declines Amid Losses

Horizon Technology Finance Corporation reports a significant net decrease in net assets for Q2 2025, driven by realized and unrealized investment losses, despite stable investment income.

Summary

• Net decrease in net assets resulting from operations was $(20.8) million for the three months ended June 30, 2025, compared to $(9.1) million for the same period in 2024.
• For the six months ended June 30, 2025, the net decrease in net assets resulting from operations was $(42.2) million, a significant worsening from $(0.5) million in the prior year period.
• Net asset value per common share decreased to $6.75 as of June 30, 2025, down from $8.43 as of December 31, 2024.
• Total investment income decreased by 4.5% to $24.5 million for the three months ended June 30, 2025, and by 5.3% to $49.0 million for the six months ended June 30, 2025, compared to the respective prior year periods.
• The company realized net losses on investments totaling $(9.3) million for both the three and six months ended June 30, 2025, contrasting with net gains of $2.5 million for the same periods in 2024.
• Net unrealized depreciation on investments was $(22.2) million for the three months ended June 30, 2025, and $(54.3) million for the six months ended June 30, 2025.
• As of June 30, 2025, five debt investments were on non-accrual status, with an aggregate cost of $74.8 million and a fair value of $26.9 million, an increase from four investments totaling $44.8 million cost and $10.5 million fair value as of December 31, 2024.
• The weighted average credit rating of debt investments deteriorated to 3.0 as of June 30, 2025, from 3.1 as of December 31, 2024.
• Unfunded commitments totaled $149.0 million as of June 30, 2025, down from $181.0 million as of December 31, 2024.
• The company's undistributed spillover income as of June 30, 2025, was $0.94 per share.
• During the six months ended June 30, 2025, $12.5 million in outstanding principal of the 2031 Convertible Notes was converted into 1,621,503 shares of common stock at a weighted average conversion price of $7.79.
• On August 7, 2025, the company entered into a Merger Agreement with Monroe Capital Corporation (MRCC), subject to shareholder approvals and other closing conditions.

Sentiment

Score: 3

Explanation: The significant net decrease in net assets, substantial unrealized depreciation, and increase in non-accrual investments indicate a challenging financial period. While there are some positive operational aspects like increased fee income and strategic facility extensions, the overall financial performance and portfolio quality deterioration suggest a negative outlook. The announced merger could be a positive long-term strategic move, but the immediate financial results are concerning.

Positives

• Fee income, including prepayment fees, increased by 89.3% to $1.9 million for the three months ended June 30, 2025, primarily due to a higher aggregate amount of principal prepayments.
• Successfully amended and extended key credit facilities (Key Facility, NYL Facility, Nuveen Facility), securing continued access to financing.
• The Board authorized an increase in the stock repurchase program from up to $5.0 million to up to $10.0 million, allowing for potential repurchases when shares trade below 90% of net asset value.
• The company expects the purchase of substantially all of the remaining assets of Powerscourt Investments XXV, LP for $22.5 million on August 6, 2025, to be accretive to its net asset value when reported in the third quarter financial results.

Negatives

• Experienced a significant net decrease in net assets resulting from operations of $(20.8) million for Q2 2025 and $(42.2) million for H1 2025.
• Net asset value per common share declined substantially from $8.43 at December 31, 2024, to $6.75 at June 30, 2025.
• Reported net realized losses on investments of $(9.3) million for both the three and six months ended June 30, 2025.
• Incurred substantial net unrealized depreciation on investments totaling $(22.2) million for Q2 2025 and $(54.3) million for H1 2025.
• The number of debt investments on non-accrual status increased to five as of June 30, 2025, from four at December 31, 2024, indicating deteriorating credit quality in parts of the portfolio.
• The weighted average credit rating of debt investments slightly deteriorated from 3.1 to 3.0.
• A realized loss on extinguishment of debt of $(0.8) million was incurred due to the conversion of 2031 Convertible Notes.

Risks

• Interest rate risk: Changes in general interest rate levels can impact net income, particularly as most debt investments are at floating rates and credit facilities have floating interest rate provisions.
• Credit risk: Investments are primarily in development-stage companies in technology, life science, healthcare, and sustainability, which often have limited operating histories and may experience variations in operating results, increasing the risk of loss of principal.
• Liquidity risk: Many portfolio companies require additional capital to meet working capital needs and debt service obligations, and the company has significant unfunded commitments ($149.0 million as of June 30, 2025).
• Market volatility and supply chain risk: Geopolitical events, rising energy prices, and strong consumer demand can affect portfolio companies' profit margins.
• RIC status compliance: Failure to meet certain source-of-income, asset diversification, and annual distribution requirements could result in corporate-level income tax, substantially reducing net assets and distributions.
• Valuation uncertainty: The fair value of investments without readily available market values is inherently uncertain and may fluctuate significantly, potentially differing materially from ultimately realized values.
• Incentive fee structure: It is possible to pay an incentive fee even if the company incurs a loss due to realized and unrealized capital losses, as the fee is based on Pre-Incentive Fee Net Investment Income.
• Convertible Notes dilution: The conversion of 2031 Convertible Notes into common stock can be dilutive to common stockholders.
• Investment concentration risk: Investment income can fluctuate significantly upon repayment of large debt investments, as the five largest debt investments accounted for a notable portion of interest and fee income.

Future Outlook

The company expects to raise additional equity and debt capital opportunistically as needed to support future growth, subject to market conditions and regulatory limits. It believes its current cash, cash generated from operations, and funds available from credit facilities will be sufficient to meet working capital and capital expenditure commitments for at least the next 12 months. The recent purchase of Powerscourt Investments XXV, LP assets for $22.5 million is expected to be accretive to the company's net asset value when reported in the third quarter.

Management Comments

• "We expect the purchase to be accretive to our net asset value when reported in our financial results for the third quarter."

Industry Context

Horizon Technology Finance operates as a specialty finance company focused on venture lending to development-stage companies in the technology, life science, healthcare information and services, and sustainability industries. The company's performance is significantly impacted by the broader venture capital and equity fundraising market, which is noted as 'difficult' in the filing. This challenging environment has contributed to the underperformance of certain portfolio companies, leading to increased unrealized depreciation and a rise in non-accrual investments. As a Business Development Company (BDC), it is subject to specific regulatory requirements regarding leverage and distributions, which influence its operational and financial strategy.

Comparison to Industry Standards

• The company's asset coverage for borrowed amounts was 166% as of June 30, 2025, which exceeds the BDC regulatory requirement of at least 150%, indicating compliance with leverage limits.
• The increase in non-accrual investments (from 4 to 5) and the deterioration of the weighted average credit rating of debt investments from 3.1 to 3.0 suggest a potential underperformance in portfolio quality compared to industry peers with more stable credit profiles.
• The significant net decrease in net assets resulting from operations and substantial unrealized depreciation on investments indicate challenges in portfolio performance, potentially lagging behind more robust segments of the venture lending or broader financial services industry.

Corporate Governance

Related Party Transactions

• The company has an Investment Management Agreement with Horizon Technology Finance Management LLC (the Advisor), which includes a base management fee and an incentive fee structure.
• An Administration Agreement is in place with the Advisor, under which the company reimburses the Advisor for allocable overhead and administrative expenses.
• The company and its Advisor rely on exemptive relief from the SEC to co-invest with other investment vehicles managed by the Advisor, Monroe, and their affiliates.
• A change in control of the Advisor occurred on March 31, 2025, when Momentum US Bidco LLC acquired 75% of the outstanding equity interests of Monroe Capital Intermediate Holdings, LLC, the indirect parent company of the Advisor.
• HIMV LLC, an entity formed to acquire assets of a past borrower (IMV), is 70% owned by the company and 30% by a third-party co-lender.

Stakeholder Impact

• Shareholders: Experienced a significant decrease in Net Asset Value (NAV) per share and net decrease in net assets, indicating a negative financial impact. Potential for dilution from convertible notes. The expanded stock repurchase program offers a potential benefit if shares are bought back below NAV. The announced merger with MRCC introduces future strategic implications.
• Employees (Access Persons): Subject to a comprehensive Joint Code of Ethics governing personal securities transactions, conflicts of interest, and insider trading, ensuring high ethical standards.
• Customers (Portfolio Companies): Continue to receive financing through existing credit facilities and unfunded commitments, although some are experiencing financial distress, leading to non-accrual status.
• Creditors: The company's debt obligations are being managed, with some debt converted to equity. The asset coverage ratio remains above the regulatory minimum, providing some assurance of the company's ability to meet its obligations.

Next Steps

• Proceed with the merger with Monroe Capital Corporation (MRCC), subject to shareholder approvals and other closing conditions.
• Continue opportunistic raising of additional equity and debt capital to support future growth.
• Potentially repurchase common stock under the expanded $10.0 million stock repurchase program when shares trade below 90% of net asset value.
• Monitor unfunded commitments and anticipated refinancings and maturities to ensure sufficient liquidity.
• The Board will annually review and consider reapproval of the Investment Management Agreement.
• Monroe and the Advisor will continue with their new exemptive relief application to modify co-investment relief.

Key Dates

Recommendation

The significant decline in Net Asset Value (NAV) per share, substantial net realized and unrealized losses on investments, and an increase in non-accrual loans indicate a deteriorating portfolio quality and poor financial performance for the period. While the company has extended credit facilities and announced a merger, the immediate financial results are concerning. The deterioration in the weighted average credit rating of debt investments further highlights increased risk. These factors suggest a negative outlook for the stock in the short to medium term, warranting a 'sell' recommendation for investors seeking to mitigate further losses or reallocate capital to more stable opportunities.

Keywords

Venture Lending, BDC, Technology Finance, Life Science Finance, Healthcare Finance, Sustainability Finance, Secured Debt, Warrants, Investment Income, Net Asset Value, Unrealized Depreciation, Non-Accrual Loans, Credit Facilities, Convertible Notes, Merger Agreement, Monroe Capital Corporation, Stock Repurchase Program